ArticleBMJ open2024

Phase II study in children and adults under 40 years with newly diagnosed Langerhans cell histiocytosis: protocol for an LCH-19-MSMFB clinical trial in Japan.

Rintaro Ono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.